Modeling & Simulation in Regulatory Science | 규제 과학의 모델링 및 시뮬레이션 혁신
Modeling and simulation are transforming regulatory science, enhancing drug development efficiency and safety assessments.
국내외 이슈들
Modeling and simulation are transforming regulatory science, enhancing drug development efficiency and safety assessments.
Nvidia, Lenovo, and Samsung will gauge consumer interest in AI-powered devices at CES, showcasing the next wave of AI integration into everyday tech.
The US economy showed unexpected strength with a 4.3% growth rate, but persistent inflation poses ongoing challenges.
University venture fund launches accelerator program in 2025, boosting early-stage startup investment and innovation.
Generative AI is reshaping industries, offering new possibilities and efficiencies. Discover the transformative impact in 2025.
Modeling & simulation are revolutionizing drug development & regulatory science, offering faster, cheaper, and more reliable results.
OpenAI is reportedly acquiring Jony Ive’s hardware company, signaling a move into AI-powered hardware development.
The US economy expanded at a robust 4.3% in Q3, exceeding expectations and signaling resilience amidst global economic uncertainties.
Korea cracks down on policy fund ‘brokers,’ raising concerns about startup capital access. Will this improve integrity or hinder innovation?
Expert insights on the AI trends shaping 2026 and how leaders can adapt to maintain a competitive edge in the rapidly evolving landscape.